(Q43981461)

28 November 2017

Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group (English)

1 reference

28 November 2017

Shinichi Uesato

1

1 reference

28 November 2017

Manabu Kitagawa

2

1 reference

28 November 2017

Yasuo Nagaoka

3

1 reference

28 November 2017

Taishi Maeda

4

1 reference

28 November 2017

Hiroshi Kuwajima

5

1 reference

28 November 2017

Takao Yamori

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

3

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

28 November 2017

12

1 reference

28 November 2017

10

1 reference

28 November 2017

1347-1349

1 reference

Histone acetylation in chromatin structure and transcription

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

Histone acetylation and transcriptional regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900175-0

7 January 2021

10.1016/S0960-894X(02)00175-0

Identifiers

DOI

1 reference

28 November 2017

1 reference